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Rationale:
within 2 hours of their collection poses limitations to its wider applicability. A way to bypass this hurdle would be to freeze the 
sample at the time of collection and to examine it at a later stage.  
Methods and Subjects: We developed a protocol for freezing of sputum upon collection by adding dimethylsulfoxide to it. We 
tested the reproducibility of cell counts in frozen samples and in fresh portions from the same sputum specimens. We took sputum 
from 41 asthmatics (18 males) with different levels of control of their disease: 19 of the samples were spontaneously produced 
and 22 were induced with hypertonic saline. 
Results:
neutrophils, eosinophils and macrophages in the paired fresh and frozen sputum samples. Cell viability in frozen sputum was 
had better reproducibility than the spontaneous ones. 
Conclusion: Examination of frozen sputum samples does not change total cell counts and differential cell counts, despite con-
but one examined specimens. Biomed Rev 2018; 29: 83-88
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INTRODUCTION
Sputum is formed into the lower airways and is expected to 
this rationale sparked the interest of Harry Morrow Brown, who 
found that asthmatic patients with eosinophils in their sputum 
readily respond to prednisolone (1). In the following years 
continuing attempts had been made to differentiate between 
asthma and chronic bronchitis on the basis of microscopical 
chemical analysis of sputum (2-4). However, it was only in the 
90s of last century that the method of sputum examination was 
upgraded and proven to be reliable, valid and feasible in studying 
airway diseases. The crucial breakthrough came as a result of 
introduction in the sputum processing protocol of a step meant 
to disengage the sputum cells from their glycoprotein matrix 
(5-7). This made possible quantitative evaluation of all cellular 
components in sputum, thus characterizing more thoroughly 
pathogenic mechanisms in asthma, other airway diseases and 
their variants. Differential cell counts (DCC) of sputum cells 
turned out to be the most important determinant of various 
Actually, most sputum studies focused on the cellular content 
and sputum soluble markers played an auxiliary role. With the 
highlight on sputum cells, an important concept was reinforced 
that sputum samples induced by inhalation of hypertonic saline 
aerosols had higher cell viability and better quality of the end 
cellular suspensions than spontaneous sputum samples (8). 
Sputum induction and examination withstood the test of 
time and imposed itself as a valuable tool in clinical research 
(9, 10). However, there are certain limitations to the wider ap-
plicability of sputum studies in clinical practice. Among them 
hours of their collection in order to get reliable cell counts. This 
certainly is a problem when sputum is to be collected away 
from the processing lab. A way to bypass this hurdle would be 
to freeze the sample at the time of collection and examine it at 
a later stage at the convenience of the investigators. 
We have developed a protocol for sputum freezing on 
collection and subsequent processing. We needed to investi-
gate the applicability of this approach by comparing it to the 
standard procedure used until now. We are limiting ourselves 
to cellular outcomes, as cells are most likely to suffer from 
the freezing and thawing procedure.
METHODS
Subjects
Forty-one subjects (18 males) from among the asthmatic sub-
jects volunteered to provide sputum samples for this study. All 
of them signed informed consent forms in conformity with the 
principles of Good Clinical Practices and the Declaration of 
Helsinki. They were with different levels of control of their 
asthma as judged by the severity of their symptoms, spirom-
of them was severely ill, 15 (36.6 %) had evidence of atopy, 13 
(31.7%) were non-smokers, 9 (22.0%) were smokers, and 19 
(46.3%) ex-smokers. Nineteen of them were able to expecto-
rate sputum spontaneously, while in the rest 22 patients, sputa 
were induced with inhalation of 3, 4 and 5% hypertonic saline. 
All patients signed informed Ethics Committee approved con-
sent forms in conformity with the principles of Good Clinical 
Practices and the Declaration of Helsinki.
Laboratory measurements
Sputum induction. Sputum induction was performed as de-
and pretreatment with salbutamol, subjects inhaled 3, 4 and 
5% hypertonic saline for 7 minute periods. After each period 
they tried to cough out sputum into plastic containers.
Sputum freezing and storage. Right after collection the spu-
tum specimens were poured into Petri dishes and the portions 
originating from the lower airways were selected and put into 
Eppendorf tubes. After putting aside the part of the specimen 
(DMSO, Merck, Germany) were added to the tube. The tubes 
were then sealed, shaken vigorously by hand for 30 seconds, 
coded, and stored in a freezer at -70°C.
Sputum processing. Fresh sputum samples were processed 
within 30 minutes after collection, following the established 
protocol. The frozen sputum samples were processed, after 
being kept at -70°C for at least two days. We used a previously 
tubes were left at room temperature to thaw and weight of 
their content was measured. Ten times diluted solution of 
dithiothreitol (DTT) (Sputalysin, Calbiochem Corp., La Jolla, 
Ca) was added to the sputum in a four times bigger volume 
(in μL) than the sputum weight (in mg). The mixture was well 
homogenized by vortexing for 30 seconds and rocking for 
15 minutes. Addition of Delbecco phosphate buffered saline 
(D-PBS) equal in volume to the DTT followed, after which 
(Spectrum, TX, USA). After centrifugation at 1000 rpm for 
10 minutes, the cell pellet was resuspended in 0.4 ml D-PBS. 
Cell viability was assessed by trypan blue exclusion using 
Burker’s hemocytometer and total cell count (TCC) [×10^3 
cells per mg of sputum] was calculated on the basis of the 
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hemocytometer count, taking into consideration the overall 
dilution. Cytospins were made from the resuspended mate-
rial using a Hettich Universal cytocentrifuge (Tuttlingen, 
May-Grunwald Giemsa. Differential counts were made on the 
basis of 400 non-squamous cells by two observers, blinded to 
the origin of the separate slides and the objectives of the study. 
The frozen sputum samples were processed according to 
the same protocol after leaving the Eppendorf tubes at room 
temperature to thaw. All subsequent dilutions took into ac-
Data analysis
Descriptive statistics were used to characterize the subjects in 
the study. Reliability Analysis procedure was used to compare 
the measurements in fresh and frozen sputum. It provided 
information about the relationships between individual items 
computed as a measure of reproducibility / reliability of the 
measurements. Variables characterizing the fresh and the 
frozen sputum samples were also correlated using Pearson’s 
of the analysis of variance (data with suspected non-normal 
distribution as in the case of sputum eosinophils, neutrophils 
and macrophages were log-transformed for this purpose). A 
two-tailed probability p < 0.05 was considered statistically 
Windows software.
Results
cell counts (TCC), the relative and absolute numbers of 
neutrophils, eosinophils and macrophages in the fresh and 
frozen sputum samples (Table 1).
The numbers (both relative and absolute) of lymphocytes 
and bronchial epithelial cells were too low to allow sensible 
statistical inferences.
of total cell counts and the number of eosinophils, neutrophils 
and macrophages of the fresh and frozen samples. However, 
viability of the cells: the viability of the cells in the frozen 
sputum was consistently lower (Fig. 1). However, only one 
frozen sputum sample had viability below 50%.
We analyzed the same outcomes separately for the spon-
taneous and the induced sputum paired samples. This strati-
layout, but the level of consistency of counts in the induced 
sputum samples was somewhat better, reaching also a statisti-
of fresh and frozen specimens (Table 2).
fresh and frozen sputum samples. The quality of bot fresh 
and frozen induced sputum samples was superior to the qual-
ity of the fresh + frozen spontaneously coughed out sputum 
specimens.
Table 1. Relationships between different cellular characteristics of paired fresh and frozen sputum samples.
Paired samples











0.322 0.040 0.49 0.019
Viability 0.202 0.205 0.32 0.115
% neutrophils 0.592 0.001 0.74 0.000
Absolute number of 
neutrophils 0.333 0.034 0.48 0.020
% eosinophils 0.871 0.001 0.92 0.000
Absolute number of 
eosinophils 0.781 0.001 0.88 0.000
% macrophages 0.631 0.001 0.77 0.000
Absolute number of 
macrophages 0.691 0.001 0.73 0.000
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Discussion
Examination of sputum has proven itself to be a reliable 
non-invasive research method to assess the nature and level 
has not gained wide application as a routine method for the 
diagnosis and monitoring of asthma so far (12). One of the 
hurdles preventing its wider application is the time coupling of 
sputum collection to its subsequent processing in the existing 
protocols. This would certainly hamper the use of sputum in 
samples collection around the clock.
In this paper we have demonstrated that freezing sputum at 
the time of collection and processing it at a later stage is not 
its main cellular components: neutrophils, eosinophils and 
macrophages. We limited ourselves to cellular outcomes, 
as cells are most likely to be vulnerable to the freezing and 
thawing procedure. We have obtained fairly good concordance 















Figure 1.  Upon thawing frozen 
sputum samples displayed rela-
tively high cell viability, which was 
consistently lower than in freshly 
processed samples. 
Table 2.   Comparison between paired fresh and frozen sputum samples from induced and spontaneously obtained specimens
Paired samples









TCC 0.49 0.081 0.71 0.004
Viability -0.17 0.627 0.59 0.022
% neutrophils 0.55 0.049 0.84 0.000
Absolute number of 
neutrophils 0.66 0.014 0.35 0.167
% eosinophils 0.82 0.000 0.97 0.000
Absolute number of 
eosinophils 0.72 0.004 0.96 0.000
% macrophages 0.49 0.080 0.88 0.000
Absolute number of 
macrophages 0.35 0.186 0.80 0.000
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of the cellular measurements in the fresh and frozen sputum 
samples. The only characteristic slightly but consistently lower 
in the frozen samples was cell viability. We have no plausible 
explanation, as to why there should be such a marginal differ-
ence. It may be the case that there is a steady subpopulation 
of (aging?) cells, which are naturally more prone to acute 
physical stimuli. However, we have proven that it does not 
substantially alter the differential cell counts in the frozen 
specimens. It has been suggested before, that low cell viability 
may compromise the results of the examination. A threshold 
of 50% viability has been proposed as a safe low limit to reli-
able results13, 14. In our case, we must point out that we had 
a TCC < 50% in only one of the frozen spontaneous sputum 
samples, which is the cut-off suggested for reliability of the 
sputum cell measurements (9, 13).
In our study the mean viability (± SD) of the fresh sputum 
samples was rather high: 83.8 ± 11.8 %. A possible explana-
tion for this result was the fact that we began the processing of 
our fresh specimen within 30 minutes after collection (current 
standard protocols would suggest processing within 2 hours 
of collection). The time lag between sputum collection and 
freezing was even shorter, as it was done immediately before 
the processing of the fresh portions of specimens. The mere 
preparation of the sputum sample for freezing is very brief 
and can be performed virtually anywhere. There is no time lag 
between sputum thawing and processing (15, 16).
Our work also provides evidence that examination of 
paired fresh and frozen induced sputum samples gives more 
consistent results than spontaneous ones. This is in line with 
the already established superiority of induced to spontaneous 
sputum in terms of reproducibility of cell counts and slide 
quality (8). We observed better quality of the cytospin slides 
of the induced sputum specimens (both fresh and frozen), 
compared with the spontaneous fresh and frozen samples, 
achieved with the spontaneous and induced fresh and frozen 
sputum samples in our study. This has enabled us to conduct 
studies at places far away from specialized laboratories (15) 
Examination of sputum continues to be a gold standard 
for non-invasive studies of airway pathology. New prospects 
have opened up with the continuously proposed many dozens 
-
tometry and different ‘-omics’ approaches (17-19). However 
for the basic needs of distinguishing the major asthma, chronic 
obstructive pulmonary disease (COPD) and asthma-COPD 
overlap, standard cell counts are the indispensable outcome. 
Freezing of sputum samples upon their collection makes pos-
sible processing of this fragile biological material to be done 
at centralized laboratories at the convenience of their skilled 
technicians.
CONCLUSIONS
The protocol we have developed for freezing the sputum 
sample upon collection and examining it at a later stage at the 
convenience of the technician is yielding cell counts consistent 
with those of fresh sputum. Freezing sputum does not alter 
our understanding that induced sputum ensures higher quality 
of the slides and better reproducibility of the measurement.
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